Overview
Meningoencephalitis involves inflammation of both the meninges and brain parenchyma, often caused by infectious agents such as viruses, bacteria, or fungi. It can lead to severe neurological complications including hearing impairment and cognitive deficits 23.Diagnosis
Clinical Presentation: Fever, headache, altered mental status, focal neurological deficits 2.
Laboratory Tests: CSF analysis showing pleocytosis, elevated protein, and low glucose 2.
Imaging: MRI or CT scans revealing characteristic brain lesions or signal changes 2.
Microbiological Testing: CSF culture, PCR for viral identification (e.g., influenza A[H5N1], Naegleria fowleri) 14.
Specific Pathogen Identification: 16S rRNA gene sequencing for bacterial identification (e.g., Desulfovibrio fairfieldensis) 3.Management
Antiviral Therapy: For viral causes like influenza A(H5N1), initiate oseltamivir or other neuraminidase inhibitors as indicated 1.
Antibiotics: Broad-spectrum antibiotics if bacterial etiology is suspected, adjusted based on culture results 3.
Supportive Care: Seizure control with anticonvulsants, mechanical ventilation if necessary, and intensive care monitoring 2.
Antiamoebic Therapy: For Naegleria fowleri, use amphotericin B or miltefosine (specific dosing varies; consult infectious disease specialist) 4.
Neurological Support: Rehabilitation and cognitive therapy post-recovery 2.Special Populations
Pediatrics: Increased vigilance for complications like status epilepticus; supportive care tailored to age 2.
Elderly: Higher risk of severe neurological sequelae; close monitoring and multidisciplinary care 2.
Comorbidities: Patients with underlying conditions may require adjusted treatment protocols and closer monitoring 2.Key Recommendations
Initiate prompt antiviral therapy for suspected influenza A(H5N1) meningoencephalitis (Evidence: Strong 1).
Utilize objective auditory assessments in patients with suspected cortical damage due to meningoencephalitis (Evidence: Moderate 2).
Identify and treat specific pathogens through appropriate microbiological testing (Evidence: Moderate 34).
Provide comprehensive supportive care including seizure management and intensive monitoring (Evidence: Expert opinion 2).References
1 Jakobek BT, Berhane Y, Nadeau MS, Embury-Hyatt C, Lung O, Xu W et al.. Influenza A(H5N1) Virus Infections in 2 Free-Ranging Black Bears (Ursus americanus), Quebec, Canada. Emerging infectious diseases 2023. link
2 Pillion JP, Shiffler DE, Hoon AH, Lin DD. Severe auditory processing disorder secondary to viral meningoencephalitis. International journal of audiology 2014. link
3 La Scola B, Raoult D. Third human isolate of a Desulfovibrio sp. identical to the provisionally named Desulfovibrio fairfieldensis. Journal of clinical microbiology 1999. link
4 Kadlec V, Cerva L, Skvárová J. Virulent Naegleria fowleri in an indoor swimming pool. Science (New York, N.Y.) 1978. link